• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇通过抑制 PIM-1 激酶活性抑制胃癌细胞增殖和存活。

Resveratrol suppresses gastric cancer cell proliferation and survival through inhibition of PIM-1 kinase activity.

机构信息

Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, South Korea; Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul 08826, South Korea.

Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul 08826, South Korea.

出版信息

Arch Biochem Biophys. 2020 Aug 15;689:108413. doi: 10.1016/j.abb.2020.108413. Epub 2020 May 27.

DOI:10.1016/j.abb.2020.108413
PMID:32473133
Abstract

The proviral integration site for Moloney murine leukemia virus (PIM) family of serine/threonine-specific kinases consist of three isoforms, that regulate proliferation, apoptosis, metabolism, invasion, and metastasis of cancer cells. Among these, abnormally elevated kinase activity of PIM-1 contributes to the progression of gastric cancer and predicts poor prognosis and a low survival rate in gastric cancer patients. In the present study, we found that resveratrol, one of the representative chemopreventive and anticarcinogenic phytochemicals, directly binds to PIM-1 and thereby inhibits its catalytic activity in human gastric cancer SNU-601 cells. This resulted in suppression of phosphorylation of the proapoptotic Bad, a known substrate of PIM-1. Resveratrol, by inactivating PIM-1, also inhibited anchorage-independent growth and proliferation of SNU-601 cells. To understand the molecular interaction between resveratrol and PIM-1, we conducted docking simulation and found that resveratrol directly binds to the PIM-1 at the ATP-binding pocket. In conclusion, the proapototic and anti-proliferative effects of resveratrol in gastric cancer cells are likely to be mediated through suppression of PIM-1 kinase activity, which may represent a novel mechanism underlying its chemopreventive and anticarcinogenic actions.

摘要

莫洛尼鼠白血病病毒(Moloney murine leukemia virus,Mo-MLV)原病毒整合位点(proviral integration site)家族的丝氨酸/苏氨酸特异性激酶包含三个同工型,这些同工型调节癌细胞的增殖、凋亡、代谢、侵袭和转移。在这些同工型中,PIM-1 的激酶活性异常升高,促进了胃癌的进展,并预测胃癌患者预后不良和生存率低。在本研究中,我们发现白藜芦醇(resveratrol)是一种代表性的化学预防和抗癌植物化学物质,可直接与 PIM-1 结合,从而抑制人胃癌 SNU-601 细胞中 PIM-1 的催化活性。这导致促凋亡 Bad 的磷酸化受到抑制,Bad 是 PIM-1 的已知底物。通过使 PIM-1 失活,白藜芦醇还抑制了 SNU-601 细胞的非锚定依赖性生长和增殖。为了了解白藜芦醇与 PIM-1 之间的分子相互作用,我们进行了对接模拟,发现白藜芦醇直接结合在 PIM-1 的 ATP 结合口袋。综上所述,白藜芦醇在胃癌细胞中的促凋亡和抗增殖作用可能是通过抑制 PIM-1 激酶活性介导的,这可能代表其化学预防和抗癌作用的一种新机制。

相似文献

1
Resveratrol suppresses gastric cancer cell proliferation and survival through inhibition of PIM-1 kinase activity.白藜芦醇通过抑制 PIM-1 激酶活性抑制胃癌细胞增殖和存活。
Arch Biochem Biophys. 2020 Aug 15;689:108413. doi: 10.1016/j.abb.2020.108413. Epub 2020 May 27.
2
Pan-Pim Kinase Inhibitor AZD1208 Suppresses Tumor Growth and Synergistically Interacts with Akt Inhibition in Gastric Cancer Cells.泛 Pim 激酶抑制剂 AZD1208 抑制胃癌细胞的肿瘤生长并与 Akt 抑制协同作用。
Cancer Res Treat. 2019 Apr;51(2):451-463. doi: 10.4143/crt.2017.341. Epub 2018 Jun 6.
3
2-Thioxothiazolidin-4-one Analogs as Pan-PIM Kinase Inhibitors.2-硫代噻唑烷-4-酮类似物作为泛 PIM 激酶抑制剂。
Chem Pharm Bull (Tokyo). 2021;69(9):854-861. doi: 10.1248/cpb.c21-00264.
4
PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).PIM 激酶对于慢性淋巴细胞白血病细胞的存活(PIM2/3)和 CXCR4 介导的微环境相互作用(PIM1)是必不可少的。
Mol Cancer Ther. 2014 May;13(5):1231-45. doi: 10.1158/1535-7163.MCT-13-0575-T. Epub 2014 Mar 21.
5
PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species.PIM激酶抑制剂通过降低Nrf2信号传导和增加活性氧来杀死缺氧肿瘤细胞。
Mol Cancer Ther. 2016 Jul;15(7):1637-47. doi: 10.1158/1535-7163.MCT-15-1018. Epub 2016 May 16.
6
A review on structure-function mechanism and signaling pathway of serine/threonine protein PIM kinases as a therapeutic target.丝氨酸/苏氨酸蛋白PIM激酶作为治疗靶点的结构-功能机制及信号通路综述
Int J Biol Macromol. 2024 Jun;270(Pt 1):132030. doi: 10.1016/j.ijbiomac.2024.132030. Epub 2024 May 3.
7
New Mechanistic Insight on the PIM-1 Kinase Inhibitor AZD1208 Using Multidrug Resistant Human Erythroleukemia Cell Lines and Molecular Docking Simulations.多药耐药人红白血病细胞系和分子对接模拟对 PIM-1 激酶抑制剂 AZD1208 的新作用机制研究。
Curr Top Med Chem. 2019;19(11):914-926. doi: 10.2174/1568026619666190509121606.
8
Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies.在血液系统恶性肿瘤模型中单独及联合抗癌药物对新型泛 PIM 激酶抑制剂 INCB053914 的临床前特征进行研究。
PLoS One. 2018 Jun 21;13(6):e0199108. doi: 10.1371/journal.pone.0199108. eCollection 2018.
9
Insights into the Interaction Mechanisms of the Proviral Integration Site of Moloney Murine Leukemia Virus (Pim) Kinases with Pan-Pim Inhibitors PIM447 and AZD1208: A Molecular Dynamics Simulation and MM/GBSA Calculation Study.深入研究 Moloney 鼠白血病病毒(Pim)激酶原病毒整合位点(Pim)与泛 Pim 抑制剂 PIM447 和 AZD1208 的相互作用机制:分子动力学模拟和 MM/GBSA 计算研究。
Int J Mol Sci. 2019 Oct 30;20(21):5410. doi: 10.3390/ijms20215410.
10
AZD1208, a Pan-Pim Kinase Inhibitor, Has Anti-Growth Effect on 93T449 Human Liposarcoma Cells via Control of the Expression and Phosphorylation of Pim-3, mTOR, 4EBP-1, S6, STAT-3 and AMPK.AZD1208,一种泛 Pim 激酶抑制剂,通过控制 Pim-3、mTOR、4EBP-1、S6、STAT-3 和 AMPK 的表达和磷酸化,对 93T449 人脂肪肉瘤细胞具有抗生长作用。
Int J Mol Sci. 2019 Jan 16;20(2):363. doi: 10.3390/ijms20020363.

引用本文的文献

1
Alternative medicines in oncology: a focus on natural products against gastric cancer.肿瘤学中的替代医学:聚焦于抗胃癌的天然产物
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 22. doi: 10.1007/s00210-025-04058-2.
2
Implication of protein post translational modifications in gastric cancer.蛋白质翻译后修饰在胃癌中的意义
Front Cell Dev Biol. 2025 Feb 4;13:1523958. doi: 10.3389/fcell.2025.1523958. eCollection 2025.
3
A literature review of recent advances in gastric cancer treatment: exploring the cross-talk between targeted therapies.
胃癌治疗最新进展的文献综述:探索靶向治疗之间的相互作用
Cancer Cell Int. 2025 Jan 24;25(1):23. doi: 10.1186/s12935-025-03655-8.
4
Molecular insights and inhibitory dynamics of flavonoids in targeting Pim-1 kinase for cancer therapy.黄酮类化合物靶向Pim-1激酶用于癌症治疗的分子见解与抑制动力学
Front Pharmacol. 2024 Oct 7;15:1440958. doi: 10.3389/fphar.2024.1440958. eCollection 2024.
5
Current Knowledge about Gastric Microbiota with Special Emphasis on Related Gastric Conditions.关于胃微生物群的当前知识,特别强调相关胃部疾病
Curr Issues Mol Biol. 2024 May 20;46(5):4991-5009. doi: 10.3390/cimb46050299.
6
Identification of anti-gastric cancer effects and molecular mechanisms of resveratrol: From network pharmacology and bioinformatics to experimental validation.白藜芦醇抗胃癌作用及其分子机制的鉴定:从网络药理学和生物信息学到实验验证
World J Gastrointest Oncol. 2024 Feb 15;16(2):493-513. doi: 10.4251/wjgo.v16.i2.493.
7
Microbiota-Gastric Cancer Interactions and the Potential Influence of Nutritional Therapies.微生物群-胃癌相互作用及营养疗法的潜在影响。
Int J Mol Sci. 2024 Jan 30;25(3):1679. doi: 10.3390/ijms25031679.
8
Identifying natural products for gastric cancer treatment through pharmacophore creation, 3D QSAR, virtual screening, and molecular dynamics studies.通过药效团创建、3D-QSAR、虚拟筛选和分子动力学研究鉴定胃癌治疗的天然产物。
Daru. 2023 Dec;31(2):243-258. doi: 10.1007/s40199-023-00480-0. Epub 2023 Sep 21.
9
Anticancer applications of phytochemicals in gastric cancer: Effects and molecular mechanism.植物化学物在胃癌中的抗癌应用:作用及分子机制
Front Pharmacol. 2023 Jan 12;13:1078090. doi: 10.3389/fphar.2022.1078090. eCollection 2022.
10
Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway-Related Prognostic Prediction Model in Gastric Cancer.胃癌中JAK-STAT信号通路相关预后预测模型的m6A修饰鉴定与验证
Front Genet. 2022 Jul 19;13:891744. doi: 10.3389/fgene.2022.891744. eCollection 2022.